Related Experiment Videos
[Experimental systems in CML biology]
1Department of Genetics, Institute of Medical Science, University of Tokyo.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|January 5, 2002
Summary
The BCR-ABL oncogene drives chronic myeloid leukemia (CML) by transforming progenitor cells. Various biological assays and models help unravel CML's molecular basis and clinical manifestations.
Area of Science:
- Hematology
- Oncology
- Molecular Biology
Context:
- The BCR-ABL oncogene on the Philadelphia chromosome is a known driver of human chronic myeloid leukemia (CML).
- Understanding the molecular mechanisms of BCR-ABL-induced leukemogenesis is crucial for CML research.
Purpose:
- To review and discuss the various biological assays and animal models used to study the molecular basis of BCR-ABL oncogene-induced CML.
- To highlight new biological activities and advanced animal models for investigating CML.
Summary:
- Established assays include mouse bone marrow cell transformation, Rat1 fibroblast transformation, cytokine-independent growth, retroviral murine CML models, and transgenic mice.
- Emerging biological activities like anti-apoptosis and anti-DNA repair offer insights into CML's clinical presentation.
- The NOD/SCID transplantation and conditional transgenic models represent advanced systems for studying cell dynamics in CML.
Impact:
- Provides a comprehensive overview of tools for CML research.
- Facilitates deeper understanding of leukemic transformation.
- Supports the development of novel therapeutic strategies for CML.